{"id":"https://openalex.org/W2394054841","doi":null,"title":"Effect of immunotherapy with the monoclonal antibody OC_(859) on survival rate and immunoreaction of patients with ovarian cancer","display_name":"Effect of immunotherapy with the monoclonal antibody OC_(859) on survival rate and immunoreaction of patients with ovarian cancer","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2394054841","mag":"2394054841"},"language":"en","primary_location":{"id":"mag:2394054841","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-SZYX200503002.htm","pdf_url":null,"source":{"id":"https://openalex.org/S10968516","display_name":"Journal of reproductive medicine","issn_l":"0024-7758","issn":["0024-7758"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of reproductive medicine","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102327404","display_name":"Lijuan Lian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I2801228662","display_name":"Peking Union Medical College Hospital","ror":"https://ror.org/04jztag35","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801228662"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Lijuan Lian","raw_affiliation_strings":["Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I2801228662"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5102327404"],"corresponding_institution_ids":["https://openalex.org/I200296433","https://openalex.org/I2801228662"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3568826,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.8510000109672546},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6779999732971191},{"id":"https://openalex.org/keywords/survival-rate","display_name":"survival rate","score":0.9380000233650208},{"id":"https://openalex.org/keywords/human-anti-mouse-antibodies","display_name":"human anti-mouse antibodies","score":0.843999981880188},{"id":"https://openalex.org/keywords/t-cell-subsets","display_name":"T cell subsets","score":0.8700000047683716},{"id":"https://openalex.org/keywords/cd4-cd8-ratio","display_name":"CD4/CD8 ratio","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemotherapy-duration","display_name":"chemotherapy duration","score":0.5519999861717224},{"id":"https://openalex.org/keywords/immune-response","display_name":"immune response","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9036944508552551},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6931515336036682},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6818959712982178},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6536653637886047},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5921240448951721},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5774504542350769},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5212790966033936},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.4781968593597412},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4646439552307129},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4560508728027344},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.4548637270927429},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42893338203430176},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30662763118743896}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2394054841","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-SZYX200503002.htm","pdf_url":null,"source":{"id":"https://openalex.org/S10968516","display_name":"Journal of reproductive medicine","issn_l":"0024-7758","issn":["0024-7758"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of reproductive medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1964034932","https://openalex.org/W1976913414","https://openalex.org/W2039279058","https://openalex.org/W2088298750","https://openalex.org/W2396352684","https://openalex.org/W1414458693","https://openalex.org/W2052570036","https://openalex.org/W2087515216","https://openalex.org/W2031454503","https://openalex.org/W2000868615"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"evaluate":[2],"the":[3,6,12,52,80,87,94,102,115,128,136,158,175,185,192,204,213,227,230],"effect":[4],"of":[5,16,38,90,160,184,191,203,218,229],"monoclonal":[7],"antibody(MAb)":[8],"OC_":[9],"859":[10,25,34,152,187,209,232],"on":[11,238],"survival":[13,112,130,138,214],"and":[14,29,51,76,83,118,124,133,141,194,215],"immunoreaction":[15],"patients":[17,50,58,163,193,219,239],"with":[18,23,164,220,240],"ovarian":[19,39,165,221,241],"cancer.Methods:":[20],"105":[21],"cases":[22,31],"MAbOC_":[24,33,151,186,208,231],"therapy":[26,35,188,210],"(MAb":[27],"group)":[28,37],"125":[30],"without":[32,174],"(control":[36],"cancer":[40,166],"were":[41,59,65,147],"studied":[42],"retrospectively.":[43],"Human":[44],"anti-mouse":[45],"antibody":[46],"(HAMA)":[47],"in":[48,56,67,93,101,114,162,172,189,201],"25":[49],"T":[53],"cell":[54],"subsets":[55],"15":[57],"also":[60],"examined.Results:":[61],"No":[62],"significant":[63],"differences":[64],"found":[66],"age,":[68],"first":[69],"cytoreductive":[70],"surgery,":[71],"FIGO":[72],"staging,":[73],"histological":[74],"type":[75],"pathological":[77],"grade":[78],"between":[79],"MAb":[81,95,116],"group":[82,96,104,117,120],"control":[84,103,119],"group,":[85],"but":[86],"mean":[88,111],"number":[89],"chemotherapy":[91],"courses":[92,197],"was":[97,121,167],"longer":[98],"than":[99,170],"that":[100,157,171,226],"(10.9":[105],"vs":[106],"8.2":[107],"respectively,":[108],"P0.01).":[109],"The":[110,154,207],"time":[113],"(91\u00b16)":[122],"months":[123,126],"(62\u00b17)":[125],"respectively;":[127,135],"3-year":[129],"rate,":[131,139],"65.7%":[132],"41.1%":[134],"5-year":[137],"62.2%":[140],"36.2%":[142],"respectively":[143],"(P0.001).":[144],"HAMA":[145],"titers":[146],"significantly":[148,211],"elevated":[149],"after":[150,181,195],"treatment.":[153],"results":[155],"showed":[156],"ratio":[159],"CD_4/CD_8":[161],"much":[168],"lower":[169],"women":[173],"disease.":[176],"It":[177],"came":[178],"to":[179],"normal":[180,200],"one":[182],"course":[183],"majority":[190],"two":[196],"it":[198],"became":[199],"all":[202],"patients.":[205],"Conclusion:":[206],"improved":[212],"immunological":[216],"responses":[217],"cancer.":[222,242],"These":[223],"data":[224],"suggest":[225],"application":[228],"has":[233],"some":[234],"therapeutic":[235],"beneficial":[236],"effects":[237]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}